Johan Sjodahl
Chief Tech/Sci/R&D Officer presso ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profilo
Johan Sjodahl is currently the Chief Scientific Officer at ISR Immune System Regulation Holding AB since 2021.
He has a graduate and doctorate degree from the Royal Institute of Technology.
Posizioni attive di Johan Sjodahl
Società | Posizione | Inizio |
---|---|---|
ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Formazione di Johan Sjodahl
Royal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
ISR Immune System Regulation Holding AB
ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Johan Sjodahl